EA200801573A1 - Способ получения кристаллических форм орлистата - Google Patents

Способ получения кристаллических форм орлистата

Info

Publication number
EA200801573A1
EA200801573A1 EA200801573A EA200801573A EA200801573A1 EA 200801573 A1 EA200801573 A1 EA 200801573A1 EA 200801573 A EA200801573 A EA 200801573A EA 200801573 A EA200801573 A EA 200801573A EA 200801573 A1 EA200801573 A1 EA 200801573A1
Authority
EA
Eurasian Patent Office
Prior art keywords
orlistat
crystalline forms
obtaining crystalline
obtaining
crystalline form
Prior art date
Application number
EA200801573A
Other languages
English (en)
Other versions
EA015940B1 (ru
Inventor
Игор Симониц
Примоз Бенкиц
Анамария Вайс
Андрейка Крамар
Антон Стимац
Original Assignee
Крка Товарна Здравил
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36354129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801573(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Крка Товарна Здравил filed Critical Крка Товарна Здравил
Publication of EA200801573A1 publication Critical patent/EA200801573A1/ru
Publication of EA015940B1 publication Critical patent/EA015940B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к способу получения кристаллических форм орлистата, в частности орлистата кристаллической формы I и орлистата кристаллической формы II.
EA200801573A 2005-12-27 2006-12-27 Способ получения кристаллических форм орлистата EA015940B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05028489A EP1803714A1 (en) 2005-12-27 2005-12-27 Process for preparing crystalline forms of orlistat
PCT/EP2006/012544 WO2007073937A2 (en) 2005-12-27 2006-12-27 Process for preparing crystalline forms of orlistat

Publications (2)

Publication Number Publication Date
EA200801573A1 true EA200801573A1 (ru) 2008-10-30
EA015940B1 EA015940B1 (ru) 2011-12-30

Family

ID=36354129

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801573A EA015940B1 (ru) 2005-12-27 2006-12-27 Способ получения кристаллических форм орлистата

Country Status (5)

Country Link
EP (2) EP1803714A1 (ru)
EA (1) EA015940B1 (ru)
NO (1) NO20083269L (ru)
UA (1) UA91733C2 (ru)
WO (1) WO2007073937A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat
PL2002825T3 (pl) * 2007-06-14 2013-12-31 Krka Kompozycje farmaceutyczne zawierające orlistat
WO2009040827A1 (en) * 2007-09-24 2009-04-02 Biocon Limited A process for obtaining tetrahydrolipstatin
EP2141236A1 (en) 2008-07-03 2010-01-06 KRKA, D.D., Novo Mesto Process for production of lipstatin and microorganisms therefore
US20120022274A1 (en) * 2009-01-22 2012-01-26 Umesh Sannachikkanna Crystalline Form of Orlistat and a Process Thereof
BR112020000635B1 (pt) 2017-07-12 2023-04-18 Mayo Foundation For Medical Education And Research Inibidores de lipases, seus usos e composição farmacêutica
WO2021072773A1 (zh) * 2019-10-18 2021-04-22 山东新时代药业有限公司 一种奥利司他胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
ES2185523T3 (es) * 1999-01-29 2003-05-01 Hoffmann La Roche Purificacion de lipstatina.
SI1307264T1 (en) * 2000-07-28 2005-02-28 F. Hoffmann-La Roche Ag New pharmaceutical composition
PT1311260E (pt) * 2000-08-09 2008-05-02 Hoffmann La Roche Utilização de inibidores de lipase para o tratamento da dispepsia
IL162323A0 (en) * 2001-12-04 2005-11-20 Biogal Pharmaceutical Co Preparation of orlistat and orlistat crystalline forms
PT1673359E (pt) * 2003-09-12 2009-10-06 Ranbaxy Lab Ltd Processo para a preparação de formas cristalinas de orlistat
EP1803714A1 (en) 2005-12-27 2007-07-04 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing crystalline forms of orlistat

Also Published As

Publication number Publication date
EP1973893B1 (en) 2015-04-29
UA91733C2 (ru) 2010-08-25
WO2007073937A2 (en) 2007-07-05
EA015940B1 (ru) 2011-12-30
NO20083269L (no) 2008-09-19
EP1803714A1 (en) 2007-07-04
WO2007073937A3 (en) 2007-08-23
EP1973893A2 (en) 2008-10-01

Similar Documents

Publication Publication Date Title
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
CY1115036T1 (el) Μεθοδος για παραγωγη χειραλικων 8-(3-αμινο-πιπεριδιν-1-υλο)-ξανθινων
EA200900793A1 (ru) Способ получения эзетимиба и его производных
CR9253A (es) Fijacion de la dosificacion de anticuerpos her
EA201300253A1 (ru) Способ получения эпоксида
BRPI0414599A (pt) pirrol-indóis substituìdos
EA200970580A1 (ru) Таннат разагилина
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
ATE543390T1 (de) Dimensionsstabiles heimtierfutter mit niedrigem kohlenhydratgehalt
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200702586A1 (ru) Кристаллические модификации пираклостробина
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
EA200901529A1 (ru) Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения
NO20071309L (no) Fremgangsmate for ekspansjon
EA200702643A1 (ru) Антитела, связывающие tweak
EA200700199A1 (ru) Способ получения дигидроптеридинонов
EA200801109A1 (ru) Состав для литья и способ его получения
EA200801573A1 (ru) Способ получения кристаллических форм орлистата
DE502006005053D1 (de) Spritzbare akustikmassen
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
EA200970126A1 (ru) Способ получения прегабалина и его энантиомера
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM